Clinically, previous studies have shown that posttransplant cancer recurrence and metastasis are significantly correlated with many factors, including tumor size and number (24), microvascular invasion (25), elevated AFP level (26, 27) and poorly differentiated tumor grade (4). The gene discussed is AFP; the disease is neoplasm.